Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study. - Wikidata - awgldk - TriplyDB

Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study.

Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study.

http://www.wikidata.org/entity/Q33694218

about

Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use Cardiovascular disease risk scores in the current practice: which to use in rheumatoid arthritis?Participation in Clinical Research Registries: A Focus Group Study Examining Views From Patients With Arthritis and Other Chronic Illnesses.Use of data from multiple registries in studying biologic discontinuation: challenges and opportunities Inconsistent treatment with disease-modifying antirheumatic drugs: a longitudinal data analysis Effects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data.Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registries.Associations of smoking and alcohol consumption with disease activity and functional status in rheumatoid arthritis.Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms.Validity of the Nurses' health study physical activity questionnaire in estimating physical activity in adults with rheumatoid arthritis Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement.Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis.Rheumatoid arthritis quality measures and radiographic progression.PTPN22.6, a dominant negative isoform of PTPN22 and potential biomarker of rheumatoid arthritis.Behavioral and clinical factors associated with self-reported abnormal Papanicolaou tests in rheumatoid arthritis Subgrouping of patients with rheumatoid arthritis based on pain, fatigue, inflammation, and psychosocial factors.Development of a multi-biomarker disease activity test for rheumatoid arthritis Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort study The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis.Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study.Clinical characteristics of RA patients with secondary SS and association with joint damage Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.Sustained rheumatoid arthritis remission is uncommon in clinical practice.Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis.Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis.Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia Do rheumatologists know best? An outcomes study of inconsistent users of disease-modifying anti-rheumatic drugs Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.Multimorbidity and rheumatic conditions-enhancing the concept of comorbidity.Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update.Automatic prediction of rheumatoid arthritis disease activity from the electronic medical records Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR)Assessment of Confounders in Comparative Effectiveness Studies From Secondary Databases.Cardiovascular disease in patients with rheumatoid arthritis.The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs.Physical Activity and Correlates of Physical Activity Participation Over Three Years in Adults With Rheumatoid Arthritis.Association of Low Bone Mineral Density with Anti-Citrullinated Protein Antibody Positivity and Disease Activity in Established Rheumatoid Arthritis: Findings from a US Observational Cohort.Fibromyalgia and the Prediction of Two-Year Changes in Functional Status in Rheumatoid Arthritis Patients.[Biomarkers for prognosis of response to anti-TNF therapy of rheumatoid arthritis: Where do we stand?].

P2860

Q28068930-89829AB9-89EE-4598-A094-23540FCB4701 Q28082992-DF9788F1-3D77-4D67-8158-CD02049EE57B Q30488431-2D42E38F-7995-4B00-A93D-06C18877ECBA Q30678187-CFA3BDF4-F6CF-4410-BF9F-73A18129ADB5 Q30860792-05D3761C-7F16-43BC-AE26-148FF31E4BA9 Q30984829-E6386CF9-9816-45C2-B80E-C73030C23FCE Q33568343-6E05C3B5-FF6C-40DE-9060-550622E435B1 Q33596873-1452831D-95AD-460E-854E-70EB77537E90 Q33747444-09521A50-0FAA-4C05-8CDB-46E34AE81E17 Q33749962-7947B0B3-3EAB-4BC7-AE45-4C3B922CA130 Q33795738-B602A25E-3FCF-49BB-A424-F04AAFABD22F Q33829662-13838AFA-6C05-4EB4-AE59-6685DF9BA8C6 Q33953283-61A79891-218B-4269-A739-B107BFDC00A8 Q34031181-E5DF8D9A-565A-4B37-AB22-796BAA73E72B Q34154461-8E97C354-B88C-4381-9F76-D3AEDE08F9DB Q34301896-5612EB28-D469-4ECF-AC63-BF6B02EC019B Q34667793-D15D16DD-7569-447C-8B8C-E33F13F0B2C0 Q35096891-9226E65D-2210-4409-B397-E47981FD9C6B Q35135726-E31B988B-D844-49F4-AF74-75DADFDB1CB8 Q35557868-2FFEB770-E388-4EB0-A06F-034C5C4AFDEF Q35558691-78395D23-959C-465F-AD10-CFACA8AC360D Q35766847-D20BCD15-08E4-4BA6-8651-184ABC217E52 Q36245761-A5CAC971-4930-4144-8DC2-A383D67604F5 Q36428250-FB856AE9-A3CA-469B-B3CC-62F7CF1D8846 Q36464352-02661C86-74EF-49DE-92E0-AA5C3458B3EF Q36674075-2FEC5FE6-AB30-41C9-B3E3-C378725E656D Q36696967-74F32B4E-DC6C-4668-8E8C-04E85BF959A1 Q36830635-2B57E46D-0913-49C9-943D-BE5802477913 Q38084444-0702E5A9-735F-4E65-9429-C4E8B6A346EB Q38178003-6DF5144F-921E-40A4-A561-36C0A574FA76 Q38195630-A3526F5E-49F1-4CF3-B8EF-42705EB215E1 Q38445673-2514CA82-32D6-4A5F-B83D-39E93A9EE578 Q38621658-4512DEF9-B34E-4DBD-A8B0-7AF23FB70CB2 Q38842054-F94DE61A-8AEE-4639-9C56-102AAD92778B Q38950371-AE284AAF-2E2E-483A-A878-38DC57C0ABB3 Q40748946-27CD86D2-238D-4B74-9E6A-DEA73C793C36 Q47874353-81695DD2-2D91-4D61-99B9-3BC34D8882D3 Q48503661-465FAF51-F810-46E8-92CC-48B21964CF3C Q50901847-DABEC5AB-B681-4232-9672-00EA981C1DDD Q52862596-695218A1-92EF-4E19-99ED-BC03CE7DE2DD

P2860

Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study.

http://www.wikidata.org/entity/Q33694218

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Using genetic and clinical dat ...... id Arthritis Sequential Study.

@ast

Using genetic and clinical dat ...... id Arthritis Sequential Study.

@en

type

label

Using genetic and clinical dat ...... id Arthritis Sequential Study.

@ast

Using genetic and clinical dat ...... id Arthritis Sequential Study.

@en

prefLabel

Using genetic and clinical dat ...... id Arthritis Sequential Study.

@ast

Using genetic and clinical dat ...... id Arthritis Sequential Study.

@en

P1433

Q33694218-2FD31168-64BB-4F29-A775-BA5532734F7A

P1476

Q33694218-A1D19B52-82AA-4E34-AD6B-ADCB53DC3116

P2093

Q33694218-2F2E8877-FA2E-4030-8348-C9B90C236EDE

Q33694218-39CF5B7D-C349-4E24-AD1F-23CD60947210

Q33694218-3F69E60E-B206-4B92-935B-04E91ACD9540

Q33694218-45AE3ECA-3D3F-42DD-8C5F-A4BE25D51CD7

Q33694218-4B2831B6-9DC4-43CA-A874-D757B4F1FCBE

Q33694218-7C62D558-B29D-43AB-8674-E9248CD7CAF1

Q33694218-917E763B-E46C-43FB-B034-07BE133145DE

Q33694218-9E49192F-4C26-4589-B093-5707BB37D9C6

Q33694218-C1FD7A1D-D419-4C3E-9FD3-19D5BE8ADE2F

P2860

Q33694218-0875524B-7DDC-4B8B-B053-B4E04872D5DC

Q33694218-0E3BD125-35E6-496B-BA3F-EC481F5D97A4

Q33694218-30B1FE0C-FFEE-4169-ACAE-FEE167D31029

Q33694218-3A7D654D-6F18-4913-9D2A-953AA19D88F8

Q33694218-4DDCEC39-2EC6-4252-864A-4FAD906FE545

Q33694218-53AD470A-A40E-4B3D-A898-C56C118CAAAF

Q33694218-69F39853-B8A2-405B-89DD-97BE2798FF9D

Q33694218-6DC2E209-4387-41F1-A516-5F560CC58B5B

Q33694218-7559E63D-7A23-4F90-8A02-0222D7345C33

Q33694218-804A9468-C4E3-4ADD-BBF5-44DAF9DF0AFE

P304

Q33694218-C0614588-5D0B-4FBC-9BC0-59F6A568502C

P31

Q33694218-2204B1A7-E967-423B-A85E-2C9CC7A37916

P356

Q33694218-5374F87B-D4F9-4DE9-8058-F413EDD010DB

P433

Q33694218-C813EF05-C7E8-403E-8141-D8AE0020F77B

P478

Q33694218-82F7F575-20A0-4728-93CB-0188FB702C23

P577

Q33694218-86F6B863-7F00-47DE-9D2D-4D4681392242

P5875

Q33694218-CEF3C53C-ACD2-4AE9-8526-B727E2B47357

P698

Q33694218-DF6A18CA-139F-48AF-84D1-D7B02D1F24A4

P356

P1433

P1476

Using genetic and clinical dat ...... id Arthritis Sequential Study.

@en

P2093

Christine K Iannaccone

http://www.w3.org/2001/XMLSchema#string

Daniel H Solomon

http://www.w3.org/2001/XMLSchema#string

Jing Cui

http://www.w3.org/2001/XMLSchema#string

Michael E Weinblatt

http://www.w3.org/2001/XMLSchema#string

Michelle L Frits

http://www.w3.org/2001/XMLSchema#string

Nancy A Shadick

http://www.w3.org/2001/XMLSchema#string

Robert M Plenge

http://www.w3.org/2001/XMLSchema#string

Roberta J Glass

http://www.w3.org/2001/XMLSchema#string

Yvonne C Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Principal components analysis corrects for stratification in genome-wide association studies

A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

Hand bone mineral density is associated with both total hip and lumbar spine bone mineral density in post-menopausal women with RA.

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.

TNFalpha inhibitors may improve asthma symptoms: a case series of 12 patients with rheumatoid arthritis and asthma.

A broad analysis of IL1 polymorphism and rheumatoid arthritis.

The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28

Observational research methods. Research design II: cohort, cross sectional, and case-control studies.

Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk.

P304

40-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/KEQ263

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46288375

http://www.w3.org/2001/XMLSchema#string

P698

20847201

http://www.w3.org/2001/XMLSchema#string